MK-8189 | Interleukin Related interleukin-related.com

Product Name :
MK-8189

Search keywords :
MK-8189

drugId :
null

Target Vo:
Phosphodiesterase 10A

Target Vo Short Name :
PDE10A

Moa_Name:
Phosphodiesterase 10A inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Merck Sharp & Dohme Corp

Active Company_Name :
Fisher Clinical Services

Active Indication_Name:
Schizophrenia

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FEN1 (YP6039) Mouse mAb medchemexpress
Anti-Mouse CD117 Antibody Epigenetics
CDK1 Antibody: CDK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to CDK1. It can be used for WB,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts